Cargando…

Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism

There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamura, Hinako, Kokumai, Takahide, Furuya, Akiko, Suzuki, Shigeru, Tanahashi, Yusuke, Azuma, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society for Pediatric Endocrinology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534519/
https://www.ncbi.nlm.nih.gov/pubmed/33088013
http://dx.doi.org/10.1297/cpe.29.143
_version_ 1783590328175951872
author Yamamura, Hinako
Kokumai, Takahide
Furuya, Akiko
Suzuki, Shigeru
Tanahashi, Yusuke
Azuma, Hiroshi
author_facet Yamamura, Hinako
Kokumai, Takahide
Furuya, Akiko
Suzuki, Shigeru
Tanahashi, Yusuke
Azuma, Hiroshi
author_sort Yamamura, Hinako
collection PubMed
description There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 children with a definitive diagnosis of P- or T-CH by re-evaluation tests at our institution from November 1986 to October 2019. Patients who continued levothyroxine (L-T(4)) treatment after the re-evaluation tests were classified as group P (n = 19), while patients who were diagnosed with T-CH and discontinued L-T(4) treatment were classified as group T (n = 23). Initial testing performed during infancy showed that the mean serum TSH and free T4 (FT4) levels did not differ significantly between groups P and T. None of the patients in group T required an increased dosage of L-T(4) at the age of 3 yr and above while 85% of the patients in group P required increased dosages of L-T(4). Hence, T-CH was suspected in patients who did not require an increase in L-T(4) dosage at the age of 3 yr and above.
format Online
Article
Text
id pubmed-7534519
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Japanese Society for Pediatric Endocrinology
record_format MEDLINE/PubMed
spelling pubmed-75345192020-10-20 Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism Yamamura, Hinako Kokumai, Takahide Furuya, Akiko Suzuki, Shigeru Tanahashi, Yusuke Azuma, Hiroshi Clin Pediatr Endocrinol Original Article There are no recommended diagnostic criteria for transient congenital hypothyroidism (CH) during early childhood. In this study, we aimed to identify the factors that distinguish permanent (P)- and transient (T)-CH. We retrospectively analyzed the clinical, biochemical, and imaging data of 42 children with a definitive diagnosis of P- or T-CH by re-evaluation tests at our institution from November 1986 to October 2019. Patients who continued levothyroxine (L-T(4)) treatment after the re-evaluation tests were classified as group P (n = 19), while patients who were diagnosed with T-CH and discontinued L-T(4) treatment were classified as group T (n = 23). Initial testing performed during infancy showed that the mean serum TSH and free T4 (FT4) levels did not differ significantly between groups P and T. None of the patients in group T required an increased dosage of L-T(4) at the age of 3 yr and above while 85% of the patients in group P required increased dosages of L-T(4). Hence, T-CH was suspected in patients who did not require an increase in L-T(4) dosage at the age of 3 yr and above. The Japanese Society for Pediatric Endocrinology 2020-10-03 2020 /pmc/articles/PMC7534519/ /pubmed/33088013 http://dx.doi.org/10.1297/cpe.29.143 Text en 2020©The Japanese Society for Pediatric Endocrinology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Yamamura, Hinako
Kokumai, Takahide
Furuya, Akiko
Suzuki, Shigeru
Tanahashi, Yusuke
Azuma, Hiroshi
Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title_full Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title_fullStr Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title_full_unstemmed Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title_short Increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
title_sort increase in doses of levothyroxine at the age of 3 years and above is useful for distinguishing transient and permanent congenital hypothyroidism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534519/
https://www.ncbi.nlm.nih.gov/pubmed/33088013
http://dx.doi.org/10.1297/cpe.29.143
work_keys_str_mv AT yamamurahinako increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism
AT kokumaitakahide increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism
AT furuyaakiko increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism
AT suzukishigeru increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism
AT tanahashiyusuke increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism
AT azumahiroshi increaseindosesoflevothyroxineattheageof3yearsandaboveisusefulfordistinguishingtransientandpermanentcongenitalhypothyroidism